Wenqian Zhang

Dr. Wenqian Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HZHuayi Zhao
Huayi Zhao
CZChenxi Zheng
Chenxi Zheng
Huihui ZhangHuihui Zhang
Huihui Zhang
MRMaohua Rao
Maohua Rao
YLYixuan Li
Yixuan Li
GYGengbiao Yuan
Gengbiao Yuan
Objectives: The aim of this study was to improve the diagnostic performance of nuclear medicine physicians using a deep convolutional neural network (DCNN) model and validate the results with two multicenter datasets for thyroid disease by analyzing clinical single-photon emission computed tomography (SPECT) image data.Methods: In this multicenter retrospective study, 3194 SPECT thyroid images were collected for model training (n=2067), internal validation (n=514) and external validation (n=613). First, four pretrained DCNN models (AlexNet, ShuffleNetV2, MobileNetV3 and ResNet-34) for were tested multiple medical image classification of thyroid disease types (i.e., Graves’ disease, subacute thyroiditis, thyroid tumor and normal thyroid). The best performing model was then subjected to fivefold cross-validation to further assess its performance, and the diagnostic performance of this model was compared with that of junior and senior nuclear medicine physicians. Finally, class-specific attentional regions were visualized with attention heatmaps using gradient-weighted class activation mapping.Results: Each of the four pretrained neural networks attained an overall accuracy of more than 0.85 for the classification of SPECT thyroid images. The improved ResNet-34 model performed best, with an accuracy of 0.944. For the internal validation set, the ResNet-34 model showed higher accuracy (p < 0.001) when compared to that of the senior nuclear medicine physician, with an improvement of nearly 10%. Our model achieved an overall accuracy of 0.931 for the external dataset, a significantly higher accuracy than that of the senior physician (0.931 vs. 0.868, p < 0.001).Conclusion: The DCNN-based model performed well in terms of diagnosing thyroid scintillation images. The DCNN model showed higher sensitivity and greater specificity in identifying Graves’ disease, subacute thyroiditis, and thyroid tumors compared to those of nuclear medicine physicians, illustrating the feasibility of deep learning models to improve the diagnostic efficiency for assisting clinicians.

8 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LLLei Liu
Lei Liu
CQChuan Qin
Chuan Qin
KLKai Lei
Kai Lei
HZHan Zhang
Han Zhang
WZWenqian Zhang
Wenqian Zhang
Background/Objective: This study aimed to develop a new nomogram to predict the likelihood of benefit for patients with advanced HCC who can benefit from the sequential treatment of conversion therapy and radical surgery. Materials and Methods: A total of 589 patients who met the criteria were included in this study. According to a 7:3 ratio, the development group included 412 patients, while the validation group included 177 patients. The clinical outcome set for this study was whether one could benefit from radical resection after conversion therapy. Independent risk factors for the outcome were screened through univariable and multivariable Logistic regression analysis. We constructed a nomogram using independent risk factors. The areas under the receiver operating characteristic (ROC) curve, calibration curve, and clinical decision curve were used to evaluate the performance of the model. Results: Sex (OR = 2.000; 95% CI: 1.018, 3.931; p = 0.044), AFP (OR = 0.533; 95% CI: 0.313, 0.907; p = 0.020), targeted therapy and immunotherapy (OR = 3.283; 95% CI: 2.029, 5.312; p < 0.001), and postoperative TACE (OR = 6.544; 95% CI: 4.021, 10.649; p < 0.001) were identified as independent risk factors for determining whether there was a benefit. The AUCs of the nomogram for the development set and the validation set were 0.793(95% CI: 0.749–0.836) and 0.770 (95% CI: 0.697–0.844), respectively. The calibration curves and clinical decision curves of the nomogram indicate that it has good predictive performance. Conclusions: This study developed a nomogram for predicting whether HCC patients can benefit from the sequential treatment of conversion therapy and radical surgery. This is of great help for us to formulate treatment strategies for patients with advanced HCC.